CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Stroke, Cardiac Events Increased After First Stroke in Young

Published: Tue, 17 Oct 2017 11:59:54 EDT
As in older patients, the risk for recurrent stroke after an index stroke is increased in patients aged 18 to 45 years, along with the risk for cardiac events, a new study shows.
Medscape Medical News

FDA Eyes Weekly Semaglutide for Diabetes as Oral Version Advances

Published: Tue, 17 Oct 2017 11:12:55 EDT
An FDA advisory panel will address a possible retinopathy risk with the investigational once-weekly injectable GLP-1 agonist for type 2 diabetes, while an oral formulation has succeeded in a phase 2 trial.
Medscape Medical News

TCT 2017: Rich in Clinical Trials, Star Power

Published: Tue, 17 Oct 2017 10:58:42 EDT
Oscar-winner Tom Hanks headlines a conference that will feature clinical trials looking at management of left main disease, cardiogenic shock, and bioabsorbable scaffolds.
Medscape Medical News
Displaying results 7-9 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

A big step forward in linking the genome to disease risk

Published: Mon, 16 Oct 2017 13:21:19 +0000
The human genome was first mapped about 15 years ago, but scientists have yet to gain a complete understanding of how genes govern the emergence of certain diseases. Now, a team of researchers led by Princeton University has taken a big step towards reaching that goal, publishing data related to 44 different human tissue types.

Ionis digs into phase 3 data ahead of Alnylam showdown

Published: Mon, 16 Oct 2017 12:35:27 +0000
Ionis Pharmaceuticals has shared a closer look at phase 3 data on inotersen in patients with hereditary TTR amyloidosis. The antisense drug triggered a 20-point improvement against a score of neuropathy impairment, laying a marker for the upcoming showdown with Alnylam.

Roche taps Warp Drive to discover novel antibiotic classes in $387M pact

Published: Mon, 16 Oct 2017 08:17:25 +0000
Roche has teamed up with Warp Drive Bio to access novel classes of antibiotics. The Big Pharma will pay up to $387 million to license and advance certain classes from the more than 100 groups of possibly novel antibiotics Warp Drive is analyzing.
Displaying results 7-9 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top